Mirati Therapeutics (MRTX) Posts Q3 Loss of 64c/Share
Tweet
Share
E-mailGet Alerts MRTX Hot Sheet
Join SI Premium – FREE
Mirati Therapeutics (NASDAQ: MRTX) reported Q3 EPS of ($0.64), $0.12 better than the analyst estimate of ($0.76).
For earnings history and earnings-related data on Mirati Therapeutics (MRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Reading (RDI) Tops Q2 EPS by 4c
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
